These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14662639)

  • 1. Vascular protection of ACE inhibitors.
    Messerli FH
    Arch Intern Med; 2003 Dec 8-22; 163(22):2791-2; author reply 2792-3. PubMed ID: 14662639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system in the pathogenesis of vascular disease.
    Carter WH; Rosencrance G
    Arch Intern Med; 2003 Dec 8-22; 163(22):2791; author reply 2792-3. PubMed ID: 14662640
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ACE inhibition and atherogenesis].
    Schölkens BA; Landgraf W
    Internist (Berl); 2001 Sep; 42(9):1219-25. PubMed ID: 11571850
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.
    Vaughan DE
    Eur Heart J; 1998 Jul; 19 Suppl G():G9-12. PubMed ID: 9717049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is angiotensin receptor blockade antithrombotic?
    Lim HS; Lip GY
    Arch Intern Med; 2003 Dec 8-22; 163(22):2790-1; author reply 2792-3. PubMed ID: 14662638
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dangerous plaque often symptom-free. ACE inhibitors prevent rupture].
    MMW Fortschr Med; 2002 Aug; 144(33-34):52. PubMed ID: 12380145
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of the renin angiotensin system in peripheral arterial disease.
    Hobbs SD; Thomas ME; Bradbury AW
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):573-82. PubMed ID: 15531190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system and atherosclerosis.
    Grote K; Drexler H; Schieffer B
    Nephrol Dial Transplant; 2004 Apr; 19(4):770-3. PubMed ID: 15031327
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor trandolapril does not affect C-reactive protein levels in myocardial infarction patients.
    de Maat MP; Kluft C; Gram J; Jespersen J
    Circulation; 2003 Oct; 108(15):e113. PubMed ID: 14557351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ; Gums JG
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.